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ABSTRACT: Congenital anomalies of the kidney and the
urinary tract (CAKUT) represent a major source of
morbidity and mortality in children. Several factors (PAX,
SOX,WNT, RET, GDFN, and others) play critical roles
during the differentiation process that leads to the
formation of nephron epithelia. We have identified
mutations in SOX17, an HMG-box transcription factor
and Wnt signaling antagonist, in eight patients with
CAKUT (seven vesico-ureteric reflux, one pelvic
obstruction). One mutation, c.775T4A (p.Y259N),
recurred in six patients. Four cases derived from two small
families; renal scars with urinary infection represented the
main symptom at presentation in all but two patients.
Transfection studies indicated a 5–10-fold increase in the
levels of the mutant protein relative to wild-type SOX17
in transfected kidney cells. Moreover we observed a
corresponding increase in the ability of SOX17 p.Y259N
to inhibit Wnt/b-catenin transcriptional activity, which is
known to regulate multiple stages of kidney and urinary
tract development. In conclusion, SOX17 p.Y259N
mutation is recurrent in patients with CAKUT. Our data
shows that this mutation correlates with an inappropriate
accumulation of SOX17-p.Y259N protein and inhibition
of the b-catenin/Wnt signaling pathway. These data
indicate a role of SOX17 in human kidney and urinary
tract development and implicate the SOX17–p.Y259N
mutation as a causative factor in CAKUT.
Hum Mutat 31:1352–1359, 2010. & 2010 Wiley-Liss, Inc.
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Introduction
Mammalian kidneys derive from two tissue compartments of
the embryonic mesoderm, that is, the ureteric bud (UB), derived
from the Wolffian duct, and the metanephric mesenchyme (MM),
whose interaction induces the metanephric mesenchyme to trans-
differentiate into nephron epithelia [Vainio and Lin, 2002; Woolf
et al., 2004]. Failure of this mechanism, such as in ectopic or
supernumerary ureters [Kume et al., 2000; Miyazaki et al., 2000;
Nishimura et al., 1999], is considered an underlying cause of a wide
variety of renal malformation [Mackie and Stephens, 1975; Pope
et al., 1999]. Gene targeting experiments in mice have led to the
characterization of specific regulators of both the conversion of
epithelial into mesenchymal cells and the branching of the ureteric
bud. The Wingless-related signaling pathway (Wnt), for example,
is critical at several stages of the process including initiation of
metanephric development [Carroll et al., 2005], branching
[Majumdar et al., 2003], and development of the nephron [Stark
et al., 1994]. Several Wnt ligands and receptors are expressed
during kidney development and activation of the Wnt pathway
results in the translocation of b-catenin into the nucleus
[Karihaloo et al., 2005]. b-Catenin is a key transcriptional effector
of the Wnt pathway, and it was recently demonstrated that loss of
b-catenin/Wnt signaling in the developing Wolffian duct causes
defects including ectopic ureters and renal aplasia [Marose et al.,
2008]. Tight control of the Wnt pathway is critical for normal
development, and several Wnt antagonists are expressed during
kidney and urinary tract development. One example is the HMG-
box transcription factor SOX17, which is known to inhibit
canonical Wnt signaling by forming a complex with b-catenin
and TCF/LEF family members and targeting them for degradation
in a GSK3b-independent manner [Sinner et al., 2007]. Analysis of
the Genito-Urinary Development database (http://www.gudmap.
org) [McMahon et al., 2008] shows in situ hybridization and
microarray expression data demonstrating that Sox17 is expressed
at several key stages during kidney and urinary development.
Specifically, Sox17 is expressed in the ureteric bud and metanephric
mesenchyme of the developing kidney and urinary tract between
Theiler Stage 19–23 (E11.5–15.5 days after fertilization).
Here we observe a young girl with congenital defects of the
urinary tract, chronic constipation, and mild mental retardation,
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of maternal origin. This gave us the opportunity to study the
genes contained within the duplication, which include SOX17. We
have identified a p.Y259N mutation in SOX17 in this girl, and we
subsequently identified the same mutation in five additional
patients with congenital anomalies of the kidney and the urinary
tract (CAKUT). Furthermore, two patients presenting with
CAKUT carried other SOX17 mutations. Functional studies of
SOX17–p.Y259N demonstrated that this protein abnormally
accumulates in cultured kidney cells, resulting in inhibition of
the canonical Wnt signaling pathway. Given the vital role of this
pathway in multiple stages of kidney development, we propose a
model by which elevated levels of mutant SOX17–p.Y259N
protein inhibit Wnt signaling resulting in abnormal kidney and
urinary tract development.
Materials and Methods
Patients
Fifty-eight familial cases with vesico ureteral reflux (VUR)
belonging to 10 small families were analyzed. In two of the families
the same p.Y259N mutation in SOX17 was found (see the Results
section). Pedigrees of the two families are shown in Figure 1A.
Family 1
Patient (II,1) was born from non consanguineous parents.
The pregnancy was achieved after in vitro fertilization (FIVET).
A Cesarean section at the 34th week of gestation was performed
because of polydramnios and a prenatal ultrasonography showing
severe bilateral hydronephrosis in the fetus. At birth, she was put
on intensive care because of her critical health conditions. In the
first 3 years of her life, she had presented mild axial hypotonia and
psychomotor development with a deficit in expressive language.
She had chronic constipation. Echocardiography showed a normal
heart with large PDA and a bidirectional shunt. Encephalic RM
demonstrated abnormal morphology of the corpus callosum,
characterized by evident thinning of the posterior portion of the
body and of the isthmus. Her right kidney showed a duplicated
pyeloureteral collecting system of about 7cm in diameter and
bilateral VUR (III). Ureteroplasty was performed to correct the
patient’s urinary defects. The patient’s mother (I,2) showed VUR
associated to megaureter with recurrent urinary infections,
chronic constipation, and coloboma of the iris in her left eye.
Her father was healthy.
Family 2
Patient (II,1) is a male child with left hydronephrosis due to
stenosis of the pyeloureteral joint. His mother (I,2) has
vesicoureteral reflux, whereas his father is healthy.
Sporadic Cases
Additionally, 178 patients with proven VUR and a history of
urinary tract infection were enrolled in the study. Control DNAs
were obtained from 88 normal subjects, 82 cord blood samples
from normal donors, and 135 patients with nephrotic syndrome.
Although the former two groups were not controlled in respect to
the presence of any defect of the urinary tract, all patients with
nephrotic syndrome had an echosonography showing normality.
The demographic and clinical data relative to all the above cohorts
are given in Table 1.
All patients with VUR had been studied with echosonography,
voiding cystography and Tc99mDMSA scan in order to verify the
presence of malformations of the kidney and urinary tract and/or
renal scars. Static renal scintigraphy was recorded 3 to 4hr after
injection of a weight-scaled dose of technetium-99m DMSA to
obtain views in the posterior and both posterior oblique
projections for 300 kilocounts or more. Focal or diffuse areas of
decreased uptake in the first scan, without evidence of cortical
loss, indicated acute pyelonephritis. Renal scarring was defined as
decreased uptake with distortion of the contours or as cortical
thinning with loss of parenchymal volume. Two nuclear
physicians, blind to the test results, interpreted the scans
independently and resolved discrepancies by discussion.
Cytogenetics, Immunofluorescence, and Array-CGH
Investigations
Chromosome preparations were made from peripheral blood,
skin, and ureter biopsies from the proposita using standard
techniques. To define the extension of the duplicated segment an
array-CGH experiment was performed using the Human Genome
CGH Microarray Kits 44B (Agilent Technologies, Palo Alto, CA)
covering the whole genome with a resolution of  100kb.
Briefly, 1mg of patient and sex-matched pooled reference DNAs
were processed according to the manufacturer’s protocol.
Fluorescence was scanned in a dual-laser scanner and the images
were extracted and analyzed with Agilent Feature Extraction
software (v9.5.3.1) and CGH Analytics software (v3.5.14),
respectively. Changes in test DNA copy number at a specific
locus are observed as the deviation of the log ratio value from a
modal value of 0.
To confirm the breakpoints, structure, and orientation of the
duplicated region we used fluorescent in situ hybridization (FISH)
Figure 1. A: Pedigrees of affected families. Family 1: I.1 healthy
father; I.2 mother with recurrent urinary infections, duplex ureter with
dilatation, chronic constipation; II.1 46,XX,dirdup(8q)(q11.1q12.1)dic,
duplex ureter dx, reflux dx (III degree), hydronephrosis sn, reflux (IV
degree), chronic constipation, thinning of the posterior portion of the
body of the corpus callosum. Family 2: I.1 Healthy father; I.2
vesicoureteral reflux; II.1 hydronephrosis sn, stenosis of the
pyeloureteral joint sn. B: Localization of mutations along the SOX17
gene coding sequence. The location of the HGM box and the G/P-rich
region are indicated. The positions of tyrosine residues () predicted
to undergo phosphorylation are also indicated. One of these residues
is the mutated Y259.
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selected according to the University of California Santa Cruz
(UCSC) Human Genome Assembly (March 2006 assembly). To
investigate the activation status of the two centromeres present on
the duplicated chromosome 8, immunofluorescence analysis was
performed by CENP-C antibody, as described [Gimelli et al., 2000].
SOX17 Mutation Analysis
DNA was extracted from lymphoblasts or whole blood sample
with the High Pure PCR Template Preparation Kit (Roche
Diagnostics, Italy). We also obtained genomic DNA from cultured
skin biopsy fibroblasts and from the proband’s ureteric tissue.
Amplification and sequencing of the SOX17 (NM_022454.2) gene
and its promoter region were performed by PCR amplification
using the following primer pairs:
SOX17 Ex1a forward: 50-ggccacatctgtgcagaaaa-30
SOX17 Ex1a reverse: 50-CTCTGGGTCTGGCTCTGGT-30
SOX17 Ex1b forward: 50-GCATCTCAGTGCCTCACTCC-30
SOX17 Ex1b reverse: 50-cgtcaggctcgcaaagaa-30
SOX17 Ex2a forward: 50-tgcgcaattcaaagtctgag-30
SOX17 Ex2a reverse: 50-CGCCGTAGTACACGTGAAGG-30
SOX17 Ex2b forward: 50-CCGGCACCTACAGCTACG-30
SOX17 Ex2b reverse: 50-cacccttttcgaggatgaga-30
All amplification reactions were performed with standard PCR
conditions in a GeneAmp 9700 PCR System (Applied Biosystems,
Foster City, CA). Unincorporated dNTPs and primers were
removed from 5ml of PCR product by digestion with 2mlo f
ExoSAP-IT (USB, Europe GmbH). Automated sequence analysis
was performed by dye-terminator reactions on an ABI3130xl
(Applied Biosystems) and electropherogram analysis by Sequencer
Software 4.6 (GeneCodes Corporation, Ann Arbor, MI).
Segregation Analysis and Somatic Cell Hybrids
Parental origin of the duplication was studied by generating
somatic cell hybrid clones to isolate the duplicated chromosome 8
from its normal homolog [Giorda et al., 2004]. Genomic DNAwas
extracted from the proposita’s EBV cell line and her parents’
lymphocytes using standard protocols; genomic DNA from hybrid
clones was extracted using DNAzol (MRC Inc., Cincinnati, OH).
Genotyping of polymorphic loci was performed by amplification
with primers labeled with fluorescent probes (ABI 5-Fam, Hex
and Tet) followed by analysis on a ABI 310 Genetic Analyzer
(Applied Biosystems). Amplifications were performed with Taq
Gold (Applied Biosystems) using standard protocols. Sequencing
reactions were performed with a Big Dye Terminator Cycle
Sequencing kit (Applied Biosystems) and run on an ABI Prism
3100 AV Genetic Analyzer.
Western Blot Analysis and Luciferase Assays
HEK293T cells were obtained from ATCC and cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Grand
Island, NY) supplemented with 10% fetal bovine serum (FBS)
(Hyclone, Logan, UT). Cells were plated into 24-well plates 24hr
prior to transfection. For Western blotting, cells were transfected
with the Sox17 plasmids (100–300ng), and a GFP plasmid (100ng)
as a transfection control, using Lipofectamine 2000 (Invitrogen,
Carlabad, CA) according to the manufacturer’s protocol. Total
amount of DNA was kept constant by adding empty vector DNA.
Total cell lysates were prepared 48hr posttransfection using RIPA
buffer and analyzed by Western immunoblotting. Antibodies used
were goat anti-Sox17 (1:5000, R&D Systems, Indianapolis, IN)
and mouse antitubulin (1:5,000; Sigma, St. Louis, MO); the
secondary antibodies were rabbit antigoat HRP (1:10,000;
Vector Laboratories, Burlingame, CA), and goat antimouse HRP
(1:10,000, Jackson ImmunoResearch, West Grove, PA). Each
experiment was repeated at least three times and a representative
sample is shown. For luciferase assays, cells were transfected with
Sox17 plasmids (3–50ng), either the TOPflash Wnt reporter
plasmid or a SOX17 luciferase reporter plasmid (50ng) [Sinner
et al., 2007], a renilla plasmid (50ng) as a transfection control,
and a constitutively active S37A b-catenin plasmid (50ng) for
the TOPflash assay. The Sox17 reporter plasmid contained eight
copies of a Sox17 binding site and the TOPflash reporter
contains TCF/LEF binding sites and were previously described
[Sinner et al., 2007; Zorn et al., 1999]. Total amount of DNA
was kept constant by adding empty vector DNA, and cell lysates
Table 1. SOX17 Mutation Analysis of Subjects with Vesicoureteral Reflux (VUR), DMSA-Positive (DMSA1UTI), and Renal Scars
Associated with Recurrent Urinary Tract Infections
Number (n) Sex (M/F)
SOX17 p.Y259N
n
SOX17 p.G178C
n
SOX17 p.Q17_S18insTQ
n
Diagnosis
(grade, position) Tc99m DMSA
CAKUT
58 (10 fam.) 26/32 4
Familial cases Fam.1, II.1 F het VUR (III grade, R&L)
double pelvis
Renal scars
Fam.1, I.2 F het VUR (IV grade, R) Normal
Fam.2, II.1 M het VUR (III grade, L) Normal
Fam. 2, I.2 F het VUR (III grade, L) Renal scars
Sporadic cases 178 57/121 2 1 1
Pt 180 F het ureter dilatation L Renal scars
Pt 240 F het VUR (III grade, L) Renal scars
Pt 253 M het VUR (I grade, R&L) Renal scars
pt 36 M het VUR (III grade, R&L) Renal scars
Controls (CT) 88 40/48 1
ct 1 M het n.a n.a
Cord blood 82 40/42 0
Nephrotic syndrome 135 60/75 0
Three groups of unselected control subjects were also analyzed. One of this included children with nephrotic syndrome who were excluded for VUR. VUR5vesicoureteral reflux;
UTI, urinary tract infections; n, number; M, male; F, female; het, heterozygote; L, left; R, right; Tc99m DMSA, Technetium99-dimercaptosuccinic acid; n.a, not available.
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et al., 2007].
Quantitative RT-PCR Analysis
For quantitative RT-PCR, total RNA was extracted from cells
using a NucleoSpin RNA II Kit (Macherey and Nagel, Germany)
and treated with RNase-free DNase (Roche, Indianapolis, IN).
cDNA was synthesized with random hexamer primers.
Real-time RT-PCR was performed using an Opticon machine (MJ
Research-Bio Rad, Hercules, CA). The primers used in this study
were: hSox17 forward 50 GAC GAC CAG AGC CAG ACC 30 and
hSox17 reverse 50 CGC CTC GCC CTT CAC C 30; hb-tubulin
forward 50 GAT ACC TCA CCG TGG CTG CT 30 and hb-tubulin
reverse 50 AGA GGA AAG GGG CAG TTG AGT 30.S Y B Rg r e e nd y e
(Qiagen, Chatsworth, CA) was included in the PCR mix. The
amount of product in each sample was estimated at the log-linear
amplification phase, and these values were normalized to the
expression level of tubulin and the data presented as a ratio of
tubulin expression.
Results
Our study began with the observation of a young girl with
congenital defects of the urinary tract, chronic constipation, and
mild mental retardation, who carried a de novo pseudodicentric
duplicated chromosome 8 (Family 1; Fig. 1A). The de novo
duplication dup(8)(q11.1q12.1) of 13.1 Mb on chromosome 8 was
demonstrated by CGH-array (Agilent 44B) and confirmed by FISH
analysis using BAC clones known to map to the duplicated region
(Fig. 2). A direct duplication was demonstrated by dual-color FISH
with BAC RP11-53M11 and CEP8. A pseudodicentric chromo-
some 8 with a inactive centromere was evidenced by FISH with
CEP8 and by immunostaining with CENP-C antibody (Fig. 2D).
These results allow us to define the karyotype of our proposita as:
46,XX,psudicdup(8)(q11.1q12.1) (chr8:46,958,053..60,381,578).
Among the 38 genes located in the duplicated region of
chromosome 8, SOX17 seemed a good candidate to study because
of its expression throughout development of the urogenital tract
in the mouse and its role in regulating b-catenin signaling. We
identified a point mutation at nucleotide 775 with respect to the
translation start site (c.775T4A) in the SOX17 gene. This
mutation results in a protein change from tyrosine at position
259 to an asparagine residue (p.Y259N). The mutation is localized
between the HMG-box and the glycine–proline-rich segment at
the C-terminal of the protein (Fig. 1B). The same mutation was
found in another family with VUR (out of 10 families for an
overall of 58 affected) and in several sporadic subjects presenting
VUR and renal scars.
Segregation analysis of the first identified patient showed the
maternal origin of the mutation. In fact, we analyzed 56 somatic
cell hybrid clones, using chromosome 8q11 markers and selected
three clones containing only the duplicated chromosome 8 and
three containing only the normal chromosome 8. Typing with a
panel of polymorphic markers demonstrated that the duplication
was of maternal origin and intrachromatidic (Supp. Table S1).
Amplification and sequencing of exon 2 of the SOX17 gene from
the proposita, her parents, and selected hybrid clones demon-
strated that in both the proposita and her mother, chromosome 8
carried the p.Y259N mutation, while the paternal chromosome 8
had a normal SOX17 allele.
The screening for SOX17 mutations was extended to 178
individuals with sporadic VUR and in 305 controls consisting of
135 children with nephrotic syndrome, 88 normal subjects without
a history of urinary infection who were not further characterized,
and 82 cord blood samples (610 chromosomes). Children with
nephrotic syndrome were chosen because all had been followed for
years with frequent urine analysis and echosonograpic evaluation.
The same p.Y259N mutation was found in two patients of the
sporadic VUR cohort, whereas two additional children carried
different SOX17 mutations (Table 1) (chi-squuare, Po0.01): one
was a point mutation (p.G178C) producing a glycine to cysteine
change at position 178, and the other (p.17Q_18SinsTQ) was
characterized by an in-frame insertion of threonine–glutamine at
position 17 (Fig. 1B and Table 1). Finally, p.Y259N was found in
one normal blood donor DNA who was recruited from our
Transfusion Unit without having any further clinical studies,
including renal sonography (Table 1).
Two (p.G178C and p.Y259N) of the three mutations described
here are localized between the HMG-box and the glycine–proline-
rich segment at the C-terminal of the protein; the other is at the
N-terminus near the HMG-box (Fig. 1B). Comparison of the
predicted amino acid sequences indicates that human and mouse
Sox17 share about 85% identity over their entire sequence,
whereas zebrafish (Dr) Sox17 shows nearly perfect conservation
only in the HMG box and the N- and C-terminal portions (Supp.
Fig. S1). The Glycine 178 residue is conserved across all three
species, while Tyrosine 259 is conserved between human and
mouse (and the frog Xenopus laevis, data not shown); the
17Q_18S residues are located in the conserved N-terminal portion
of the protein, but are not themselves conserved (Supp. Fig. S1).
Analysis of SOX17 p.Y259N Protein Activity
We investigated the impact of the p.Y259N mutation on SOX17
protein levels, SOX17 mRNA levels, transcriptional activity, and
Wnt-inhibitory activity in the kidney cell line HEK293T. Western
blot analysis of total cell extracts demonstrated that, at equal
amounts of transfected DNA, the mutant SOX17-p.Y259N protein
accumulated to much higher levels than SOX17-WT protein
(Fig. 3A). In numerous experiments we observed between 6- and
20-fold increase in protein levels as measured by Western blot and
densitometry analysis. These differences were not due differences
in mRNA levels from the transfected plasmids, because quanti-
tative RT-PCR on total RNA isolated from transfected cells
revealed that mRNA levels of wild-type and SOX17–p.Y259N-
transfected cells were largely comparable (Fig. 3B). In the example
shown, there was a slight increase (1.4-fold) in levels of
SOX17–p.Y259N mRNA relative to wild type, but this is minimal
compared to the 6- to 20-fold increase in protein levels of
SOX17–p.Y259N. We analyzed SOX17 transcriptional and Wnt-
b-catenin repressing activity by cotransfection of SOX17 with a
SOX17 reporter plasmid [Sinner et al., 2007] (Fig. 3C) and a Wnt
reporter plasmid (Fig. 3D). In all cases, the p.Y259N mutant
protein levels were significantly higher and this correlated with
higher transcriptional activity as measured by the SOX17 reporter
plasmid. Moreover, SOX17–p.Y259N suppressed Wnt-b-catenin
signaling activity two- to threefold better than wild-type SOX17
(Fig. 3D). However, when luciferase activity was approximately
normalized to SOX17 protein levels, the p.Y259N mutation did
not appear to alter the inherent transcriptional or Wnt/b-catenin
inhibitory activity of SOX17 [Sinner et al., 2007; Wodarz and
Nusse, 1998; Zorn et al., 1999]. Because we have previously
demonstrated that SOX17 can interact with b-catenin and TCF/
LEF proteins and target them for degradation, one likely
interpretation for these data is that elevated p.Y259N mutant
HUMAN MUTATION, Vol. 31, No. 12, 1352–1359, 2010 1355Figure 2. A: Array-CGH, cytogenetics, and FISH results. Ratio plot of high-resolution oligonucleotide array mapping of duplication 8q11.1–q12.1
(chr8:47655000-60101000) from the proband of Family 1. This technique evidenced a duplication of 13,1Mb spanning from probe A_14_P107002 at
47.655Mb to probe A_14_P128857 at 60.101Mb. Because the probes contained in the Agilent 44B microarray slide do not cover the region
‘‘Gap_225’’ (3Mb) from 8p11.1 to 8q11.1, between the centromere and probe A_14_P107002, we completed this interval by FISH with BAC clones.
B: Cutout and ideogram of the normal chromosome 8 (left) and the duplicated (right) chromosome 8. Parental karyotypes were normal, suggesting
that the abnormality was de novo. C: FISH with CEP8 (Vysis) showing the normal (arrowhead) and the dicentric duplicated chromosome 8 (arrow).
In fact, the CEP 8 probe evidenced the presence of a second centromere or, most likely, a partial centromere because it appeared of reduced
dimensions. D: After immunofluorescence with CENP-C, signals (green) are localized at the centromere of the normal chromosome 8 (arrowhead)
but not at the second inactive centromere of the duplicated chromosome 8 (arrow). E: Dual-color FISH with BAC probes RP11-53M11, mapping to
8q11.23, and containing the gene SOX17 (green signal), and CEP8 (Vysis), specific for alphoid DNA of chromosome 8 centromere (red signals),
showing a direct duplication of the segment 8q11.1–q12.1 (arrow); arrowhead indicates normal chromosome 8.
1356 HUMAN MUTATION, Vol. 31, No. 12, 1352–1359, 2010protein inappropriately suppresses the Wnt signaling pathway
during kidney and urinary tract development causing the above-
mentioned congenital defects.
Discussion
A complex mechanism drives the development of the urinary
tract in mammals. Both the kidney and urinary tract segments
derive from the interaction of two tissue compartments of the
embryonic mesoderm, that is, the ureteric bud (UB), derived from
the Wolffian duct, and the metanephric mesenchyme (MM), that
induces the metanephric mesenchyme to trans-differentiate into
nephron epithelia [Vainio et al., 2002; Woolf et al., 2004]. These
events are mediated by several soluble factors that act in a
cooperative fashion either as pro- or antitubulogenic factors.
Among the growing list of such molecules are the members of
the fibroblast growth factor (FGF), transforming growth factor
(TGF-b) ,a n dW n tf a m i l i e s ,a sw e l la sG D N F ,H G F ,a n dE G F
[Karihaloo et al., 2005]. b-Catenin is a key component of the
canonical Wnt signaling pathway. Several Wnts are expressed
during kidney development, and activation of the Wnt pathway can
result in localization of b-catenin to the nucleus where it activates a
pattern of gene expression that is required for normal nephron
development [Karihaloo et al., 2005]. In fact, inhibiting b-catenin/
Wnt signaling in the developing Wolffian duct results in mice with
ectopic ureters and renal malformations [Marose et al., 2008].
We report here the identification of a novel heterozygous amino
acid substitution in SOX17 in two families and several other
subjects with urinary tract malformations. Our results show that
the p.Y259N mutation causes an increase in SOX17 protein levels
in cultured kidney fibroblast cells. Tyrosine-259 is one of four
putative tyrosine-phorphorylation sites, as predicted by analysis of
SOX17 primary sequence [Blom et al., 1999]. The interactions
between protein phosphorylation and the ubiquitin–proteasome
system (UPS) are well documented [Gao and Karin, 2005; Hunter,
2007]. Specifically, a single phosphorylated residue can either
target a protein for degradation or prevent its degradation by the
UPS, depending on the protein being studied. We therefore
Figure 3. Impact of the p.Y259N mutation on SOX17 mRNA and protein levels. A: Steady-state levels of SOX17 protein are profoundly affected
by the p.Y259N mutation. A total of 100, 200, or 300ng of WT SOX17 or p.Y259N SOX17 expression plasmids were transfected into HEK293Tcells
and protein lysates were harvested after 48hr and analyzed by Western blot with an anti-SOX17 antibody, as well as an antitubulin antibody to
assess protein loading. Comparison of SOX17-WTand SOX17-p.Y259N protein levels at equal dosage of transfecting DNA (lanes 2 and 5, 3 and 6,
4 and 7) suggests that the mutation increases SOX17 protein stability. Experiment was repeated four times and a representative blot is shown.
B: SOX17 mRNA levels measured by quantitative RT-PCR. SOX17 mRNA levels in mock-transfected cells were 0.003 times that measured in cells
transfected with 10ng WT SOX17 (data not shown). N53; P50.001; Error bars represent SEM. C: The effect of the p.Y259N mutation on the
transcriptional activity of a SOX17 reporter plasmid. SOX17 expression plasmids were cotransfected with a SOX17-luciferase reporter plasmid.
The SOX17-p.Y259N protein showed enhanced activity of the reporter at every transfection dosage, relative to the SOX17-WT protein. Data are
shown as ratio of activities of firefly luciferase to control renilla luciferase. N53; Po0.05; Error bars represent SEM. D: The effect of the
p.Y259N mutation on the ability of SOX17 to repress Wnt signaling. SOX17 expression plasmids were cotransfected with a TCF-luciferase
reporter plasmid (TOP-flash) and an expression plasmid encoding a stabilized form of b-catenin. Repression of Wnt signaling was increased at
every dosage with the mutant SOX17 protein, compared to the WT protein. Data are shown as ratio of activities of firefly luciferase to control
renilla luciferase. N53; Po0.05; Error bars represent SEM.
HUMAN MUTATION, Vol. 31, No. 12, 1352–1359, 2010 1357speculate that the intracellular degradation of SOX17 is at least
partially dependent on tyrosine-phosphorylation at residue 259.
SOX17 is known to directly interact with transcriptional
effectors of the Wnt signaling pathway, b-catenin, and TCF/LEF.
SOX17 physically interacts with b-catenin to regulate SOX17
target genes [Sinner et al., 2004]. In addition, SOX17 is a potent
Wnt-signaling antagonist, and does so through direct physical
interaction with both b-catenin and TCF/LEF factors [Sinner
et al., 2007]. Formation of this trimeric complex leads to the
degradation of both b-catenin and Tcf/Lef proteins through a
GSK3-independent mechanism and loss of Wnt-signaling activity.
Consistent with SOX17 acting to inhibit the Wnt/b-catenin
pathway, our data showed that elevated SOX17 p.Y259N protein
inappropriately suppressed the Wnt signaling pathway in renal
cells. Because mice lacking b-catenin in the developing kidney
have symptoms of CAKUT, it is possible that altered levels of Wnt
signaling during development could cause the observed congenital
defects in these patients with CAKUT. Alternatively, elevated levels
of Sox17 could effect urinary tract development through
regulation of Sox17 target genes, of which several have been
identified [Patterson et al., 2008; Sinner et al., 2004].
SOX17 is expressed throughout different stages of kidney
development (http://www.gudmap.org) [Brunskill et al., 2008].
For example, in situ hybridization and microarray analysis shows
that Sox17 is highly expressed in bladder stroma and to a minor
degree in the ureteric bud and in metanephric mesenchyme at
E11.5 days after fertilization, a stage where Wnt9b acts to regulate
ureteric branching [Carroll et al., 2005]. Other Wnt ligands,
specifically Wnt2b, Wnt6, Wnt7b, and Wnt9b, as well as Sox17, are
also expressed at later stages of kidney development such as in the
S-shaped bodies, mesonephros, and metanephros, and later in the
medullary collecting duct, renal medullary interstitium, maturing
renal corpuscle, early proximal tubule, and cortical collecting duct.
Our in vitro analysis of SOX17 activity showed a clear
correlation between SOX17 protein level and the degree of
b-catenin repression, demonstrating a dose-dependent inhibitory
effect of SOX17 on Wnt signaling. This is interesting because the
proband’s duplicated chromosome 8 contained two copies of the
SOX17–p.Y259N mutation and would be predicted to exhibit a
genetic ‘‘dose-dependent’’ increase in phenotypic severity. In fact,
the patient with the duplication and two copies of SOX
17–p.Y259N, which would be predicted to have higher accumula-
tion of SOX17 and more suppression of Wnt/b-catenin, had more
severe developmental defects than the patients with one copy of
SOX 17–p.Y259N.
To our knowledge, no mutation or disease has been associated
with the SOX17 gene in humans. Only two HMG box mutations
were found in cell lines from colorectal cancers [Suraweera et al.,
2006]. The presence of SOX17 mutations in several patients with
urinary tract anomalies suggests that SOX17 is involved in
regulatory and signaling pathways controlling the normal
development of the urinary apparatus. The additional pathologi-
cal features found exclusively in the proband of Family 1, such as
psychomotor and language development delay and abnormal
corpus callosum, were very likely due to the presence of the 13-Mb
duplication spanning a portion of chromosome 8 containing over
30 genes. The reason for the rare association of SOX17 functional
mutations with diseases in humans probably resides on the fact
that to date, over 20 SOX genes have been identified in vertebrates
with closely related family members. For example, SOX17, SOX7,
and SOX18, share high structural and functional similarities and
have functional redundancies during development [Bowles et al.,
2000; Sakamoto et al., 2007; Travers, 2000]. This indicates that Sox
family members that are coexpressed in the same cell type will
functionally substitute for one another.
In conclusion, the identification of SOX17 mutations in
individuals with duplication of the urinary tract and VUR has
broad implications for the genetic workup in patients with kidney
and urinary tract malformations. SOX17 is the latest in a series of
genes (PAX2, ROBO2) whose alteration induces partial defects of
the VUR. Our observations also indirectly support a key role for
SOX17, possibly via Wnt/b-catenin/Tcf signaling pathway, in
kidney organogenesis, ureteric branching, and urinary tract
development in humans [Zhang, 2003].
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